References
Peterson K, Rosenblum MK, Kotanides H, Posner JB (1992) Paraneoplastic cerebellar degeneration: I. a clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42:1931–1937
Shams’ili S, Grefkens J, de Leeuw B et al (2003) Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126:1409–1418
Grant R, Graus F (2009) Paraneoplastic movement disorders. Mov Dis 24(12):1715–1724
Uchya M, Graus F, Rene R, Delattre JY (1996) Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry 60:388–392
Roberts WK, Darnell RB (2004) Neuroimmunology of the paraneoplastic neurological degenerations. Curr Opin Immunol 16:616–622
Dropcho EJ (1995) Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis and therapeutic options. Ann Neurol 37:S102–S113
Keime-Guibert F, Graus F, Fleury A et al (2000) Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 68:479–482
Counsell C, McLeod M, Grant R (1994) Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin. Neurol 44:1184–1185
Flora ED, Perera CL, Cameron AL, Maddern GJ (2010) Deep brain stimulation for essential tremor: a systematic review. Mov Disord 25(11):1550–1559
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rana, A.Q., Rana, A.N. & Adlul, A. Acute ataxia due to anti-Yo antibody paraneoplastic cerebellar degeneration 4 months prior to diagnosis of uterine carcinoma. Acta Neurol Belg 112, 303–304 (2012). https://doi.org/10.1007/s13760-012-0047-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-012-0047-8